Stock Quote

Hong Kong start-up Prenetics to list in the U.S. through $1.7 billion SPAC deal

Hong Kong biotech company Prenetics is going public through a merger with Artisan Acquisition — a SPAC backed by Adrian Cheng, CEO of New World Development.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.